International Trade

On July 26, the Department of Commerce, Department of the Treasury, and Department of Justice released a Tri-Seal Compliance Note (July Note) providing guidance on voluntary self-disclosure of potential violations of U.S. sanctions, export controls, and other national security laws. Continue Reading Tri-Seal Compliance Note on Voluntary Self-Disclosure Released by Departments of Commerce, Justice, and Treasury

We will speak at a Strafford webinar providing guidance to life sciences companies and research institutions that are conducting or considering conducting clinical trials outside the United States.Continue Reading [WEBINAR] Conducting Clinical Trials Outside the U.S.: U.S. and Foreign Rules, Regulations, and Guidance

I am looking forward to speaking on a panel at an upcoming Strafford webinar addressing the U.S. Department of Commerce’s recent policy shift that increases the incentives for companies to voluntarily self-disclose (VSD) possible EAR violations, particularly when “significant,” or risk serious penalties. Continue Reading [WEBINAR] Significant EAR Violations and BIS Policy Shift: Incentivized Voluntary Self-Disclosure, Third-Party Whistleblowing

Please join us for a lively and timely discussion of recent FCPA enforcement activity on Tuesday, May 23, 2023 at 1pm ET/12pm CT.Continue Reading FCPA Enforcement: New Corporate Enforcement Policy, Aggressive Enforcement, and Lessons Learned From Recent Resolutions